William S. Marth, Director at ALBANY MOLECULAR RESEARCH INC (AMRI), bought 20,000 shares at $11.57 ($231K) on 2013-11-22, disclosed to the SEC on 2013-11-22.
Open-market purchase of $231k AMRI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| AMRI | BUY | 2015-03-06 | $354K | — | Filing → |
| AMRI | BUY | 2014-11-10 | $510K | — | Filing → |
| AMRI | BUY | 2014-05-13 | $462K | — | Filing → |